⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

XLV Diagnostics (Canada)

h-index: 6
Total citations: 1,154
Total papers: 10

Homepage: http://xlvdiagnostics.com/#

Recent papers from XLV Diagnostics (Canada)

52‐week ivarmacitinib in moderate‐to‐severe atopic dermatitis: A phase 3 trialJournal of the European Academy of Dermatology and Venereology · 2026
Oral Icotrokinra for Plaque Psoriasis in Adults and AdolescentsNew England Journal of Medicine · 2025
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and AdolescentsJAMA Dermatology · 2025
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic DermatitisJAMA Dermatology · 2023
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)Journal of the European Academy of Dermatology and Venereology · 2018
Secukinumab sustains good efficacy and favourable safety in moderate-to-severe psoriasis after up to 3 years of treatment: results from a double-blind extension studyBritish Journal of Dermatology · 2017
Phase 3 Studies Comparing Brodalumab with Ustekinumab in PsoriasisNew England Journal of Medicine · 2015
A fixed-dose combination of adapalene 0.1%–BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acneJournal of Dermatological Treatment · 2011